Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Successful Worldwide First in Human Implantation of an Innovative Aortic Valve from Colibri Heart Valve and Venus Medtech with Disruptive "Dry Tissue" Technology Conducted


News provided by

Venus Medtech (Hangzhou) Inc.

28 Oct, 2016, 02:50 GMT

Share this article

Share toX

Share this article

Share toX

The joint venture entity (JVE) from Colibri Heart Valve and Venus Medtech achieve a significant milestone by advancing a next generation, disruptive, pre-packaged, ready-for-use, self-expanding transcatheter aortic heart valve.

CORRIENTES, Argentina and HANGZHOU, China, Oct. 28, 2016 /PRNewswire/ -- The joint venture entity (JVE), created by Colibri Heart Valve and Venus Medtech announce today the successful implantation of the Venibri Valve, a self-expanding, pre-packaged, ready-for-use, transcatheter aortic heart valve system in a patient at the Institute of Cardiology of Corrientes in Argentina on October 26.  The next-generation, disruptive Venibri Valve was developed by the JVE and is a milestone for the treatment of aortic valve stenosis. The Venibri Valve is the world's first self-expanding pre-loaded, pre-packaged, ready-for-use, transcatheter aortic heart valve system, which incorporates the proprietary Colibri Heart Valve "dry tissue" technology and the Venus Medtech self-expanding heart valve frame and delivery system.  The Colibri Heart Valve tissue has undergone extensive testing and was recently cleared by the U.S. FDA for use as a soft tissue repair product by Colorado Therapeutics LLC. 

This image opens in the lightbox
The Successful Worldwide First in Human Implantation of the Innovative heart valve -- Venibri

Photo: http://photos.prnewswire.com/prnh/20161027/433638

The first implantation of the Venibri Valve in a patient was performed by Prof. Mao Chen, Prof. Yuan Feng from the West China Hospital, Sichuan University, China and Dr. Jorge Baccaro from Institute of Cardiology of Corrientes in Argentina on October 26. The 82-year-old female patient suffered from severe aortic stenosis. Upon confirming the appropriate valve size for the patient, a 29mm Venibri Valve system incorporating the pre-crimped, pre-loaded, pre-packaged "dry" heart valve was removed from the package and the guidewire lumen and flush port were injected with saline to purge the system of air.  The Venibri Valve delivery system was then inserted into the femoral artery over the guidewire. The valve insertion, advancement, and deployment was smooth and stable. Upon 2/3 deployment, blood pressure recovered to a normal range indicating the leaflets were immediately functioning. The post deployment angiogram demonstrated the Venibri heart valve leaflets functioned immediately.  Total time from opening the ready-for-use Venibri THV system to valve deployment was approximately 15 minutes. With success of the first valve, on October 27, a 26mm Venibri Valve was implanted in another patient, an 81-year-old female patient with severe aortic stenosis. Total implantation from opening the package took approximately 16 minutes.

The operators were quite impressed with the clinical performance of the Venibri Valve. Prof. Chen commented, "The Venibri THV system is very easy to use and helpful in saving precious time for patients. It provides the opportunity to treat emergent, severe and critical aortic stenosis patients easily and effectively."

Prof. Horst Sievert, director of the CardioVascular Center Frankfurt, highly praised the technology, "Dry tissue technology has become another important milestone since the first ever TAVR case in 2002. These advantages of the Venibri THV system turned a complex TAVR procedure into a relatively easy one, like a PCI procedure. I believe physicians and patients will broadly benefit from this new technology."

"The advancement of the Venibri THV system is further validation for the Colibri "dry" tissue technology and compliments the previous FIH experience demonstrated with the Colibri pre-packaged, ready-for-use, balloon expandable THV system," stated Dr. R. David Fish one of the co-founders of Colibri Heart Valve.  Dr. David Paniagua, co-founder of Colibri Heart Valve also stated, "This successful first-in-human implantation of the Venibri THV system is a significant milestone demonstrating the value of the Colibri "dry" tissue technology and will be a meaningful advancement for the treatment of severe aortic valve stenosis."

"The JVE will offer both a self-expanding and balloon-expandable pre-packaged, ready-for-use, THV system to address the large and growing aortic stenosis in the Chinese and emerging Asian markets." Stated Eric Zi, president and CEO of Venus Medtech Hangzhou. "The convenience and benefits offered by the Venibri Valve will allow the JVE to successfully penetrate the significant aortic stenosis market in China and emerging Asian markets."

The JVE, through the combination of the Colibri Heart Valve and Venus Medtech technologies, will develop and commercialize both self-expanding and balloon-expandable pre-packaged, ready-for-use transcatheter heart valve (THV) systems in China and emerging Asian markets.  Colibri Heart Valve will have the rights to the JVE products for the North American, European, Japanese, Australian, and New Zealand markets.

"The recent successful first-in-human implantation of the Venibri Valve system is a testament to the technology benefits formed by the combination of the Colibri and Venus technologies," stated Joseph B. Horn, president and CEO of Colibri Heart Valve.  "We look forward to further clinical and commercial advancement of the Colibri and Venus Medtech technologies through the JVE to provide a breakthrough in advancement of patient treatment of severe aortic stenosis."

For more information, please visit www.colibrihv.com and http://en.venusmedtech.com.

Modal title

Also from this source

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart ...

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Joint Ventures

Joint Ventures

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.